Differin Dark Spot Correcting Serum

Manufacturer
Galderma Laboratories, L.P. | KIK Holdco Company Inc
Effective date
2019-05-07
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 23:39:58

Label at a glance#

ProductDifferin Dark Spot Correcting Serum
Active ingredientHydroquinone
Label structure10 sections

Indications and uses

For the gradual fading of dark (brownish) discolorations in the skin such as freckles, age and liver spots.        

Dosage and administration

■ Adults: Apply a small amount as a thin layer on the affected area twice daily, or use as directed by a doctor. If no improvement is seen after 3 months of treatment, use of this product should be discontinued. Lightening effect of this product may not be noticeable when used on very dark skin.  ■ Children under 12 years of age: do not use unless directed by a doctor. ■ Sun exposure should be limited by using a ...

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Hydroquinone 2% 

Purpose

OTC - PURPOSE SECTION

Skin Bleaching Agent

Uses

INDICATIONS & USAGE SECTION

For the gradual fading of dark (brownish) discolorations in the skin such as freckles, age and liver spots.        

Warnings

WARNINGS SECTION

For external use only.

When using this product
■ Avoid contact with eyes.  ■ Some users of this product may experience a mild skin irritation. If skin irritation becomes severe, stop use and consult a doctor.

Do not use
■ on children under 12 years of age unless directed by a doctor.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

■ Adults: Apply a small amount as a thin layer on the affected area twice daily, or use as directed by a doctor. If no improvement is seen after 3 months of treatment, use of this product should be discontinued. Lightening effect of this product may not be noticeable when used on very dark skin. 
■ Children under 12 years of age: do not use unless directed by a doctor.
■ Sun exposure should be limited by using a sunscreen agent, a sun blocking agent, or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

1,2-Hexanediol, Alcohol Denat., Caprylyl Glycol, Citric Acid, Disodium EDTA, Fragrance, Hippophae Rhamnoides Oil, Hydroxyethylcellulose, PEG-40 Hydrogenated Castor Oil, Polysorbate 20, Sodium Metabisulfite, Sodium Sulfite, Water

Questions or comments?

OTC - QUESTIONS SECTION

1-866-735-4137

OTC - QUESTIONS SECTION

Distributed by:

Galderma Laboratories, L.P.

Fort Worth, TX 76177
USA

All trademarks are the property of their respective owners.

Made in Canada

www.differin.com

Principle Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Differin Dark Spot Serum Carton
Differin Dark Spot Serum Carton

 DIFFERIN®                 

Dark Spot
Correcting Serum

2% Hydroquinone
Skin Lightener

• Gradually fades dark brownish discoloration, pigment, spots and blotches 
• Helps reduce the appearance of post acne marks
• Improves luminosity

1 FL OZ (30 mL)

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0299-46080299-4608-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1bc46fef-ff20-4c59-9d08-ec9070cd3954b430e8d4-e4e5-4eee-99ba-d98bcf9ec53f2022-03-04WarningsExact identifier
spl set id: b430e8d4-e4e5-4eee-99ba-d98bcf9ec53f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.